Status:
UNKNOWN
COPD Remote Patient Monitoring Through Connected Devices
Lead Sponsor:
Innovation Hub Enterprises
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This study is a device study that will use a double-arm. It will integrate the ANNE ONE platform which continuously tracks enrolled COPD patients' vital signs and symptoms over the course of the study...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is a diseases that causes airflow limitation and breathing-related problems, affecting approximately 16 million people in the U.S., most of which are aged ...
Eligibility Criteria
Inclusion
- Adults 40\>years
- Have a formal diagnosis of COPD
- Must be able to understand and speak English in order to complete the survey questionnaires.
- They must be able and willing to download the ANNE ONE application on a smartphone.
- Have their COPD managed by a pulmonologist.
- Have the willingness and ability to commit to the study period and completion of the surveys.
Exclusion
- Participants with a formal diagnosis of asthma will be excluded.
- Those who are unable to read and/or speak English
- Patients who exhibit physical or mental disability precluding the ability to provide informed consent will be excluded from the study.
- Those who are unable or unwilling to download the ANNE ONE application will also be excluded.
- Additionally, participant who are not willing or able to commit to the duration of the study will not be included.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05271474
Start Date
June 1 2022
End Date
August 1 2022
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital
Atlanta, Georgia, United States, 30322